107 related articles for article (PubMed ID: 6124052)
21. A long-term evaluation of nadolol, a long-acting beta-adrenergic blocking agent, in the management of hypertension in general practice.
O'Callaghan EG
Br J Clin Pract; 1982 Jun; 36(6):235-9. PubMed ID: 6128994
[No Abstract] [Full Text] [Related]
22. [Modification of hemorheologic parameters by beta-receptor blockers with special reference to propranolol and talinolol].
Böhme HR; Neupert A; Fischer W
Z Gesamte Inn Med; 1988 Aug; 43(16):450-4. PubMed ID: 2903595
[TBL] [Abstract][Full Text] [Related]
23. [The beta blocker Betaxolol--a significant alternative in hypertension therapy].
Internist (Berl); 1998 Mar; 39(3 Suppl):1-4. PubMed ID: 9562845
[No Abstract] [Full Text] [Related]
24. Effect of cimetidine on the pharmacokinetics of the new beta-blocker betaxolol.
Rey E; Jammet P; d'Athis P; de Lauture D; Christoforov B; Weber S; Olive G
Arzneimittelforschung; 1987 Aug; 37(8):953-6. PubMed ID: 2890358
[TBL] [Abstract][Full Text] [Related]
25. [New aspects of antihypertensive therapy].
Wedler B; Börner H; Schulz H; Teichmann G
Ann Acad Med Stetin Supl; 1978; Suppl 16():9-12. PubMed ID: 44441
[No Abstract] [Full Text] [Related]
26. [Betaxolol hydrochloride in the treatment of mild and medium hypertension--long-term effects].
Soucek M; Julínek J; Rihácek I; Stejfa M
Vnitr Lek; 1995 Sep; 41(9):605-8. PubMed ID: 7483351
[TBL] [Abstract][Full Text] [Related]
27. [The use of the cardioselective adrenergic beta 1-blockader cordanum in the treatment of arterial hypertension].
Zonis BIa; Brin VB
Ter Arkh; 1983; 55(5):81-3. PubMed ID: 6137077
[No Abstract] [Full Text] [Related]
28. A comparative study of celiprolol and placebo in the treatment of hypertension.
Capone P; Mayol R
Br J Clin Pract Suppl; 1985 Jun; 40():65-9. PubMed ID: 2864067
[No Abstract] [Full Text] [Related]
29. Comparative study with Tobanum and Visken in hypertensive patients.
Torma Z; Grubic V; Unyi G
Ther Hung; 1983; 31(3):129-35. PubMed ID: 6152822
[No Abstract] [Full Text] [Related]
30. [Long-term administration of trimepranol in young men with labile borderline hypertension and its influence on plasma renin activity (author's transl)].
Slabý A; Dosková M; Jirák R; Pavlát J; Urbánek J; Reisenauer R
Sb Lek; 1975 Apr; 77(4):107-11. PubMed ID: 238278
[No Abstract] [Full Text] [Related]
31. [Advantageous risk-benefit ratio of betaxolol].
Internist (Berl); 1997 Apr; 38(4 Suppl Gunstiges):1-4. PubMed ID: 9431353
[No Abstract] [Full Text] [Related]
32. Assessment of beta-blocking activity of low-dose bupranolol.
Weisser B; Noack E; Düsing R; Glänzer K
Int J Clin Pharmacol Res; 1989; 9(1):9-14. PubMed ID: 2565296
[TBL] [Abstract][Full Text] [Related]
33. Celiprolol, clinical dosage, efficacy and safety in asthmatic and elderly patients.
Hitzenberger G
Br J Clin Pract Suppl; 1985 Jun; 40():25-32. PubMed ID: 2864058
[No Abstract] [Full Text] [Related]
34. [Management of milder forms of hypertension using new beta-receptor blockaders].
Pozenel H
Adv Clin Pharmacol; 1976; 11():99-106. PubMed ID: 25573
[No Abstract] [Full Text] [Related]
35. [Nadolol + bendroflumethiazide in a fixed combination and in sequential administration. Experimental research on antihypertensive efficacy and tolerability].
Del Re ML; Ricci A; Abate G
Clin Ter; 1986 Mar; 116(5):385-90. PubMed ID: 2871962
[No Abstract] [Full Text] [Related]
36. [Clinical evaluation of a beta-blocking agent in a single daily dose].
Di Veroli C; Compagno S
Clin Ter; 1982 Jun; 101(6):623-8. PubMed ID: 6127182
[No Abstract] [Full Text] [Related]
37. [Antihypertensive action of various talinolol dosages after four week's treatment in comparison with placebo].
Weigmann I; Terhaag B; Wierich W; Herrmann WM
Arzneimittelforschung; 1998 Mar; 48(3):240-4. PubMed ID: 9553680
[TBL] [Abstract][Full Text] [Related]
38. Nadolol (corgard) in severe and resistant hypertension.
Nontak MA
Med J Malaysia; 1981 Sep; 36(3):181-5. PubMed ID: 6120443
[No Abstract] [Full Text] [Related]
39. Comparison of talinolol and atenolol effects on blood pressure in relation to lipid and glucose metabolic parameters. Results from the TALIP study.
Sourgens H; Schmidt J; Derendorf H
Int J Clin Pharmacol Ther; 2003 Jan; 41(1):22-9. PubMed ID: 12564742
[TBL] [Abstract][Full Text] [Related]
40. [Field study: long-term antihypertensive therapy with the beta blocker nadolol in a once-a-day dosage - an outpatient study of Swiss medical practices].
Bertel O; Conen D; Renggli I
Schweiz Rundsch Med Prax; 1983 Feb; 72(8):264-8. PubMed ID: 6132374
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
